The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Shuji Ogino

Center for Molecular Oncologic Pathology

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Harvard Medical School

USA

[email]@*.harvard.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, USA. 2012 - 2013
  • Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, USA. 2004 - 2012

References

  1. Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. Ogino, S., Nishihara, R., Lochhead, P., Imamura, Y., Kuchiba, A., Morikawa, T., Yamauchi, M., Liao, X., Qian, Z.R., Sun, R., Sato, K., Kirkner, G.J., Wang, M., Spiegelman, D., Meyerhardt, J.A., Schernhammer, E.S., Chan, A.T., Giovannucci, E., Fuchs, C.S. J. Natl. Cancer Inst. (2013) [Pubmed]
  2. How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Ogino, S., Fuchs, C.S., Giovannucci, E. Expert Rev. Mol. Diagn. (2012) [Pubmed]
  3. Body mass index and risk of colorectal cancer according to Fatty Acid synthase expression in the nurses' health study. Kuchiba, A., Morikawa, T., Yamauchi, M., Imamura, Y., Liao, X., Chan, A.T., Meyerhardt, J.A., Giovannucci, E., Fuchs, C.S., Ogino, S. J. Natl. Cancer Inst. (2012) [Pubmed]
  4. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Ogino, S., Chan, A.T., Fuchs, C.S., Giovannucci, E. Gut (2011) [Pubmed]
  5. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review. Shima, K., Nosho, K., Baba, Y., Cantor, M., Meyerhardt, J.A., Giovannucci, E.L., Fuchs, C.S., Ogino, S. Int. J. Cancer (2011) [Pubmed]
  6. Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Ogino, S., Nosho, K., Irahara, N., Shima, K., Baba, Y., Kirkner, G.J., Mino-Kenudson, M., Giovannucci, E.L., Meyerhardt, J.A., Fuchs, C.S. Am. J. Gastroenterol. (2010) [Pubmed]
  7. A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases. Ogino, S., Nosho, K., Irahara, N., Kure, S., Shima, K., Baba, Y., Toyoda, S., Chen, L., Giovannucci, E.L., Meyerhardt, J.A., Fuchs, C.S. Clin. Cancer Res. (2009) [Pubmed]
  8. PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. Ogino, S., Nosho, K., Kirkner, G.J., Shima, K., Irahara, N., Kure, S., Chan, A.T., Engelman, J.A., Kraft, P., Cantley, L.C., Giovannucci, E.L., Fuchs, C.S. J. Clin. Oncol. (2009) [Pubmed]
  9. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. Ogino, S., Shima, K., Baba, Y., Nosho, K., Irahara, N., Kure, S., Chen, L., Toyoda, S., Kirkner, G.J., Wang, Y.L., Giovannucci, E.L., Fuchs, C.S. Gastroenterology (2009) [Pubmed]
  10. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Ogino, S., Nosho, K., Irahara, N., Meyerhardt, J.A., Baba, Y., Shima, K., Glickman, J.N., Ferrone, C.R., Mino-Kenudson, M., Tanaka, N., Dranoff, G., Giovannucci, E.L., Fuchs, C.S. Clin. Cancer Res. (2009) [Pubmed]
  11. A cohort study of p27 localization in colon cancer, body mass index, and patient survival. Ogino, S., Shima, K., Nosho, K., Irahara, N., Baba, Y., Wolpin, B.M., Giovannucci, E.L., Meyerhardt, J.A., Fuchs, C.S. Cancer Epidemiol. Biomarkers Prev. (2009) [Pubmed]
  12. KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803. Ogino, S., Meyerhardt, J.A., Irahara, N., Niedzwiecki, D., Hollis, D., Saltz, L.B., Mayer, R.J., Schaefer, P., Whittom, R., Hantel, A., Benson, A.B., Goldberg, R.M., Bertagnolli, M.M., Fuchs, C.S. Clin. Cancer Res. (2009) [Pubmed]
  13. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. Ogino, S., Nosho, K., Irahara, N., Shima, K., Baba, Y., Kirkner, G.J., Meyerhardt, J.A., Fuchs, C.S. J. Clin. Oncol. (2009) [Pubmed]
  14. p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis. Ogino, S., Nosho, K., Shima, K., Baba, Y., Irahara, N., Kirkner, G.J., Hazra, A., De Vivo, I., Giovannucci, E.L., Meyerhardt, J.A., Fuchs, C.S. Cancer Epidemiol. Biomarkers Prev. (2009) [Pubmed]
  15. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis. Ogino, S., Nosho, K., Baba, Y., Kure, S., Shima, K., Irahara, N., Toyoda, S., Chen, L., Kirkner, G.J., Wolpin, B.M., Chan, A.T., Giovannucci, E.L., Fuchs, C.S. Am. J. Gastroenterol. (2009) [Pubmed]
  16. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Ogino, S., Nosho, K., Kirkner, G.J., Kawasaki, T., Meyerhardt, J.A., Loda, M., Giovannucci, E.L., Fuchs, C.S. Gut (2009) [Pubmed]
  17. Cohort study of fatty acid synthase expression and patient survival in colon cancer. Ogino, S., Nosho, K., Meyerhardt, J.A., Kirkner, G.J., Chan, A.T., Kawasaki, T., Giovannucci, E.L., Loda, M., Fuchs, C.S. J. Clin. Oncol. (2008) [Pubmed]
  18. Molecular classification and correlates in colorectal cancer. Ogino, S., Goel, A. J. Mol. Diagn (2008) [Pubmed]
  19. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Ogino, S., Kirkner, G.J., Nosho, K., Irahara, N., Kure, S., Shima, K., Hazra, A., Chan, A.T., Dehari, R., Giovannucci, E.L., Fuchs, C.S. Clin. Cancer Res. (2008) [Pubmed]
  20. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Ogino, S., Kawasaki, T., Nosho, K., Ohnishi, M., Suemoto, Y., Kirkner, G.J., Fuchs, C.S. Int. J. Cancer (2008) [Pubmed]
  21. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. Ogino, S., Nosho, K., Kirkner, G.J., Kawasaki, T., Chan, A.T., Schernhammer, E.S., Giovannucci, E.L., Fuchs, C.S. J. Natl. Cancer Inst. (2008) [Pubmed]
  22. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high. Ogino, S., Kawasaki, T., Kirkner, G.J., Ohnishi, M., Fuchs, C.S. BMC. Cancer (2007) [Pubmed]
  23. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Ogino, S., Kawasaki, T., Ogawa, A., Kirkner, G.J., Loda, M., Fuchs, C.S. Hum. Pathol. (2007) [Pubmed]
  24. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Ogino, S., Kawasaki, T., Kirkner, G.J., Suemoto, Y., Meyerhardt, J.A., Fuchs, C.S. Gut (2007) [Pubmed]
  25. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. Ogino, S., Kawasaki, T., Kirkner, G.J., Kraft, P., Loda, M., Fuchs, C.S. J. Mol. Diagn (2007) [Pubmed]
  26. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Ogino, S., Hazra, A., Tranah, G.J., Kirkner, G.J., Kawasaki, T., Nosho, K., Ohnishi, M., Suemoto, Y., Meyerhardt, J.A., Hunter, D.J., Fuchs, C.S. Carcinogenesis (2007) [Pubmed]
  27. CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Ogino, S., Meyerhardt, J.A., Kawasaki, T., Clark, J.W., Ryan, D.P., Kulke, M.H., Enzinger, P.C., Wolpin, B.M., Loda, M., Fuchs, C.S. Virchows Arch. (2007) [Pubmed]
  28. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Ogino, S., Kawasaki, T., Kirkner, G.J., Yamaji, T., Loda, M., Fuchs, C.S. Mod. Pathol. (2007) [Pubmed]
  29. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype. Ogino, S., Kawasaki, T., Ogawa, A., Kirkner, G.J., Loda, M., Fuchs, C.S. Hum. Pathol. (2007) [Pubmed]
  30. Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. Ogino, S., Gulley, M.L., den Dunnen, J.T., Wilson, R.B. J. Mol. Diagn (2007) [Pubmed]
  31. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. Ogino, S., Kawasaki, T., Ogawa, A., Kirkner, G.J., Loda, M., Fuchs, C.S. Hum. Pathol. (2007) [Pubmed]
  32. Bayesian risk assessment in genetic testing for autosomal dominant disorders with age-dependent penetrance. Ogino, S., Wilson, R.B., Gold, B., Flodman, P. J. Genet. Couns (2007) [Pubmed]
  33. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. Ogino, S., Kawasaki, T., Brahmandam, M., Cantor, M., Kirkner, G.J., Spiegelman, D., Makrigiorgos, G.M., Weisenberger, D.J., Laird, P.W., Loda, M., Fuchs, C.S. J. Mol. Diagn (2006) [Pubmed]
  34. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. Ogino, S., Kawasaki, T., Kirkner, G.J., Loda, M., Fuchs, C.S. J. Mol. Diagn (2006) [Pubmed]
  35. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Ogino, S., Brahmandam, M., Cantor, M., Namgyal, C., Kawasaki, T., Kirkner, G., Meyerhardt, J.A., Loda, M., Fuchs, C.S. Mod. Pathol. (2006) [Pubmed]
  36. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Ogino, S., Cantor, M., Kawasaki, T., Brahmandam, M., Kirkner, G.J., Weisenberger, D.J., Campan, M., Laird, P.W., Loda, M., Fuchs, C.S. Gut (2006) [Pubmed]
  37. Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis. Ogino, S., Brahmandam, M., Kawasaki, T., Kirkner, G.J., Loda, M., Fuchs, C.S. Mod. Pathol. (2006) [Pubmed]
  38. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. Ogino, S., Kawasaki, T., Kirkner, G.J., Ogawa, A., Dorfman, I., Loda, M., Fuchs, C.S. J. Pathol. (2006) [Pubmed]
  39. Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Ogino, S., Odze, R.D., Kawasaki, T., Brahmandam, M., Kirkner, G.J., Laird, P.W., Loda, M., Fuchs, C.S. Am. J. Surg. Pathol. (2006) [Pubmed]
  40. Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests. Ogino, S., Flodman, P., Wilson, R.B., Gold, B., Grody, W.W. Genet. Med. (2005) [Pubmed]
  41. Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. Ogino, S., Kawasaki, T., Brahmandam, M., Yan, L., Cantor, M., Namgyal, C., Mino-Kenudson, M., Lauwers, G.Y., Loda, M., Fuchs, C.S. J. Mol. Diagn (2005) [Pubmed]
  42. Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. Ogino, S., Meyerhardt, J.A., Cantor, M., Brahmandam, M., Clark, J.W., Namgyal, C., Kawasaki, T., Kinsella, K., Michelini, A.L., Enzinger, P.C., Kulke, M.H., Ryan, D.P., Loda, M., Fuchs, C.S. Clin. Cancer Res. (2005) [Pubmed]
  43. Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening. Ogino, S., Wilson, R.B., Gold, B., Hawley, P., Grody, W.W. Genet. Med. (2004) [Pubmed]
  44. New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations. Ogino, S., Wilson, R.B., Gold, B. Eur. J. Hum. Genet. (2004) [Pubmed]
 
WikiGenes - Universities